Arax Advisory Partners’s Vera Therapeutics VERA Stock Holding History
Bought
Maintained
Sold
Other funds holding VERA
KCM
Arax Advisory Partners's VERA Position: Q3 2026 in Review
Arax Advisory Partners reduced its Vera Therapeutics (VERA) stake by 36% in Q3 2026, selling an estimated $839 and leaving 43 shares worth $1.39K. The position accounts for ﹤0.01% of the portfolio, ranked #4968.
Arax Advisory Partners first reported a position in VERA in Q2 2024 and has held it in 7 quarters since. The position peaked at $3.58K in Q3 2024. 224 funds tracked by Wall St. Rank hold VERA as of Q3 2026.
- Arax Advisory Partners held 43 shares of Vera Therapeutics worth $1.39K as of Q3 2026.
- Arax Advisory Partners sold 24 Vera Therapeutics shares in Q3 2026, an estimated $839.
- Vera Therapeutics made up ﹤0.01% of Arax Advisory Partners's portfolio in Q3 2026, its #4968 holding.
- Arax Advisory Partners first reported a position in Vera Therapeutics in Q2 2024 and has held it in 7 quarters since.
- Arax Advisory Partners's Vera Therapeutics position peaked at $3.58K in Q3 2024.
- 224 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2026.
Based on Arax Advisory Partners's 13F filing for Q3 2026, filed 12 Nov 2026.